Treatment reduces risk of heart attack by 60 to 90 percent, reverses arterial plaque buildup; antioxidant vitamins diminish beneficial effect

November 28, 2001

Treatment with a combination of statin and niacin can slash the risk of a fatal or non-fatal heart attack or hospitalization for chest pain by 70 percent among patients who are likely to suffer heart attacks and/or death from coronary heart disease, according to a study by University of Washington researchers in the Nov. 29 New England Journal of Medicine.

Cardiovascular disease is the No. 1 killer in most industrialized countries.

The study also found that a mixture of antioxidant vitamins had no beneficial effect on cardiovascular outcomes.

The treatment that cut the risk for cardiovascular events combines two well-known ways of improving cardiac health: the use of a statin drug to lower levels of the "bad" cholesterol, LDL, and the use of niacin to boost levels of the "good" cholesterol, HDL. The study found that use of this combined treatment, in people with low levels of "good" HDL and average levels of "bad" LDL, could even reverse plaque buildup in the arteries.

At the start of the study and again after three years of treatment, doctors performed angiograms of the patients' arteries. The angiograms, using computerized measurements, showed that in most of the patients who received the combination treatment, plaque buildup had actually decreased.

"This is the first demonstration of a striking clinical benefit from this form of combination drug therapy used in patients with a common type of coronary disease," said Dr. B. Greg Brown, lead author of the study, a cardiologist and UW professor of medicine.

The study was funded by the National Heart, Lung, and Blood Institute (NHLBI).

"This study shows that improving cholesterol levels in people with heart disease --especially lowering LDL "bad" cholesterol substantially, together with raising HDL "good" cholesterol -- greatly reduces the risk for a heart attack and heart disease complications and can actually reverse the buildup of cholesterol in the arteries of the heart," said Dr. Claude Lenfant, director of the National Heart, Lung, and Blood Institute.

"The study also contributes to the evidence that antioxidant vitamins may not be beneficial in the treatment of heart disease."

The study found that a mixture of antioxidant vitamins blunted the expected rise in the "good" HDL cholesterol usually seen with the simvastatin and niacin combination. Scientists are not sure why this is so, since there has been laboratory evidence that suggests antioxidants should be helpful.

However, the recent "Heart Protection Study" from the United Kingdom confirmed the lack of benefit from the vitamin combination. The study had included antioxidants because there has been considerable evidence that they should help protect against the basic mechanisms for cholesterol buildup. The antioxidants involved in this study include Vitamins C, E, beta carotene and selenium.

Brown was director of the first study in the late 1980s that showed that a member of the statin class, lovastatin, could cause improvement in arterial blockage and reduce the occurrence of major cardiovascular events. Giving statins to people with cardiovascular disease is now common, and has been proven to reduce cardiovascular risk by 25 to 35 percent over five years of treatment.

Brown and colleagues had surmised that combining simvastatin with niacin might more effectively prevent heart attacks and the need for procedures such as coronary bypass. The goal would be to reduce plaque buildup. That's important because the growth of cholesterol-rich plaque blocks blood flow and can lead to fatal complications.

"What is expected with statins is a slowing of the disease progression, but not a reversal. Arteries continue to get narrower, but not as fast," Brown said. "But when niacin is combined with a statin, the artery blockage actually improves a bit, on average."

The statins lower blood levels of LDL, which is called the "bad" cholesterol because it contributes to plaque growth and arterial blockage. HDL, on the other hand, helps protect against heart disease. Niacin, or Vitamin B3, is the best agent known to raise blood levels of HDL, which helps remove cholesterol deposits from the artery walls.

The 160 patients involved in the study had low levels of HDL cholesterol (a level of 35 mg/dl or less). At least four out of every 10 people with coronary artery disease fit this profile.

Some patients in this study received simvastatin and niacin, while others received antioxidants. A third group received all these treatments, while a control group received placebos. All patients received exercise training, as well as anti-smoking and dietary counseling.

The results for those receiving statin and niacin were startlingly different from control patients. The average level of HDL increased from 31 to 39, or 26 percent, while the average LDL dropped from 125 to 76 (down 43 percent) -- that is considered an extremely good level of the bad cholesterol.

Angiograms showed that most of these people had no additional plaque buildup over the years. In many of them, the amount of plaque actually decreased.

"What we saw was a reversal of the disease," Brown said. "The patients' arteries, on average, had stopped narrowing and begun to improve somewhat. Those receiving this lipid therapy combination had 60 to 90 percent fewer major cardiovascular events than the control group."

For the patients receiving antioxidants, the progressive narrowing of the arteries and frequency of major cardiovascular events did not differ from the control patients. And those receiving lipid therapy and antioxidants had less favorable outcomes than the group that had simvastatin and niacin alone. This was due to the observed blunting of the HDL response. The study concludes that niacin adds substantially to the already proven simvastatin benefit, and that the use of antioxidant vitamins to prevent heart disease should be questioned.

The study involved use of niacin at moderately high and carefully supervised levels. Brown said that patients should only take niacin under a doctor's supervision, because in some patients, the doctor may wish to monitor the patient's liver function. Rarely, the unsupervised use of niacin can cause severe liver problems, including liver failure.
-end-
Others involved in the study include UW researchers Dr. John Albers, Dr. Xue-Qiao Zhao, Dr. Alan Chait, Dr. Lloyd Fisher, Alice Dowdy, Dr. Marian Cheung, Josiah Morse, Leny Serafini and Ellen Huss-Frechette, as well as Debbie DeAngelis and Dr. Jiri Frohlich of the University of British Columbia, Vancouver, B.C.

University of Washington

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.